SuperworthMinerva Neurosciences shares outstanding NERV
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 79.1M
- On a year earlier
- +945.1%
- more shares
Minerva Neurosciences had 79.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 945.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 11.1M | +47% |
| FY2024 | 7.6M | +0% |
| FY2023 | 7.6M | +42% |
| FY2022 | 5.3M | −0% |
| FY2021 | 5.3M | +0% |
| FY2020 | 5.3M | +9% |
| FY2019 | 4.9M | +0% |
| FY2018 | 4.9M | +0% |
| FY2017 | 4.8M | +11% |
| FY2016 | 4.4M | +41% |
| FY2015 | 3.1M | +34% |
| FY2014 | 2.3M | +258% |
| FY2013 | 644.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 79.1M | +945% | |
| Q1 FY26 | 43.9M | +480% | |
| Q4 FY25 | 11.1M | +47% | |
| Q3 FY25 | 7.6M | +0% | |
| Q2 FY25 | 7.6M | +0% | |
| Q1 FY25 | 7.6M | +0% | |
| Q4 FY24 | 7.6M | +0% | |
| Q3 FY24 | 7.6M | +0% | |
| Q2 FY24 | 7.6M | +37% | |
| Q1 FY24 | 7.6M | +42% | |
| Q4 FY23 | 7.6M | +42% | |
| Q3 FY23 | 7.6M | +42% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Minerva Neurosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.